Stemirna Therapeutics Alternatives & Competitors

12 companies similar to Stemirna Therapeutics

Santaris Pharma

Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse diseas...

Venture round $72.40M

Biotechnology Health Care +1

ADARx Pharmaceuticals Inc.

Our vision is to provide effective and safe RNA therapeutics to patients who suffer from i...

94 Series C $327.00M

San Diego, United States

Biotechnology Health Care +1

C4 Therapeutics, Inc.

Clinical-stage biotech company transforming how disease is treated through targeted protei...

111 IPO $218.00M

Watertown, United States

Biotechnology Health Care +2

Gain Therapeutics

Unfolding the next generation of allosteric small molecule therapies to meet patient needs...

26 IPO $83.04M

Bethesda, United States

Biotechnology Pharmaceutical

Track all Stemirna Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

GPCR Therapeutics

New hope for cancer patients

18 Venture round

Seoul, Korea South

Biotechnology Health and Wellness +1

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology (Nasdaq: LIXT)

6 Post-IPO Equity $10.48M

United States

Biotechnology Health Care +1

BioNTech SE

Our vision is to harness the power of the immune system to develop novel therapies against...

5202 IPO $1.49B

Mainz, Germany

Biopharma Biotechnology +2

Atlantic Healthcare

Innovating therapeutic solutions for gastrointestinal diseases and unmet patient needs wor...

Series B $62.00M

Biotechnology Health Care +1

American Gene Technologies® International Inc.

Our mission is to leverage the power of gene and cell therapy to reduce human suffering fr...

26 Series F $30.20M

Rockville, United States

Biotechnology Health Care +1

NantKwest

44 Post-IPO Equity $103.50M

Culver City, United State...

Biotechnology Health Care +1

Khondrion

Bringing energy to life

7 Grant

Nijmegen, The Netherlands

Biotechnology Pharmaceutical

Verdiva Bio

Transforming lives by accelerating innovation in cardiometabolic health

78 Series A $411.00M

London, United Kingdom

Biotechnology Pharmaceutical

Frequently Asked Questions

Companies similar to Stemirna Therapeutics include Santaris Pharma, ADARx Pharmaceuticals Inc., C4 Therapeutics, Inc., Gain Therapeutics, GPCR Therapeutics. They work in Biotechnology and Pharmaceutical.

Bounce Watch lists 12 companies that share Stemirna Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Stemirna Therapeutics is a biotechnology and pharmaceutical startup founded in 2016. The company specializes in RNA technology for drug development, with a focus on leveraging the full potential of RNA science. Stemirna Therapeutics boasts a portfolio of over a dozen independently-developed mRNA drug projects, targetin...

Don't just read about them. Follow them.

BounceWatch watches Stemirna Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Stemirna Therapeutics Profile Santaris Pharma Alternatives ADARx Pharmaceuticals Inc. Alternatives C4 Therapeutics, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Stemirna Therapeutics on 12 Sep 2024. The 10 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.